Companies / Castle Creek Biosciences
Castle Creek Biosciences
Exton, United States
Castle Creek Biosciences is conducting a registrational Phase 3 trial for patients with dystrophic epidermolysis bullosa (DEB).
Castle Creek Biosciences, based in Exton, United States, has 1 investor on file, among them Valor Equity Partners. Its site was last checked 20 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Valor Equity Partners
198 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (17%), Enterprise Software (13%), Healthcare & Biotech (11%).
See Valor Equity Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Castle Creek Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Valor Equity Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/castlecreekbio.com/investors
# also
GET /v1/companies/castlecreekbio.com
GET /v1/companies/castlecreekbio.com/news